Cannabidiol Market Size, Share, Demand and Analysis 2034
Global Cannabidiol Market Growth, Size, Trends Analysis- By Source Type, By Sales Type, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jul-2025 | Report ID: PHAR2516 | Pages: 1 - 254 | Formats*: |
| Category : Pharmaceutical | |||
Cannabidiol Market Introduction and Overview
According to SPER Market Research, the Global Cannabidiol Market is estimated to reach USD 40.01 billion by 2034 with a CAGR of 16.06%.
The report includes an in-depth analysis of the Global Cannabidiol Market, including market size and trends, product mix, Applications, and supplier analysis. The CBD market is expanding rapidly due to increasing legalization and interest in its potential health benefits. Investment in research and development is rising, and competition is growing as more companies enter the market. Consumers are willing to pay premium prices for therapeutic CBD products, prompting retailers to stock high-margin cannabis-based items. For example, Abercrombie & Fitch is introducing CBD body care in over 160 stores. Major retailers like CVS, Walgreens, and Rite Aid also now offer CBD creams, oils, edibles, and tinctures. However, The cannabidiol (CBD) oil market faces regulatory uncertainty and inconsistent laws across regions, hindering product approval and distribution. Additionally, a lack of standardized quality control and scientific validation affects consumer trust and product credibility.
By Source Type:
In 2024, the hemp segment led the cannabidiol market and is projected to grow at the fastest rate, driven by increasing demand from the pharmaceutical industry and rising consumer awareness of CBD’s health benefits. Legalization of medicinal cannabis and higher disposable incomes are further supporting this growth. The demand for CBD products—ranging from oils, tinctures, capsules, and topicals to edibles like chocolates and baked goods—is expanding rapidly. Hemp-derived CBD is gaining popularity for its anti-inflammatory, anti-aging, and antioxidant properties, fueling growth across pharmaceutical, personal care, nutraceutical, and food and beverage sectors.
By Sales Type:
The B2B segment led the market and is expected to grow rapidly, driven by a rising number of wholesalers supplying CBD oil and increasing demand for it as a raw material. Legalization in various regions has expanded opportunities for distribution. Within the B2C space, hospital pharmacies are projected to see notable growth as more companies partner with retail pharmacies to boost visibility and create dedicated CBD sections. Growing pharmacy participation and patient preference for CBD treatments further enhance market prospects.
By End Use:
The pharmaceutical segment dominates the B2B market and is expected to grow rapidly. Rising clinical trials on CBD’s health benefits are driving demand, with many companies purchasing bulk CBD oil to create products for pain and stress relief. The transition of CBD from traditional remedies to prescription drugs, combined with increased awareness of its therapeutic value, is fueling growth in this sector.
Regional Insights:
North America led the cannabidiol market in 2024 and is set for continued growth. Factors such as a health-conscious population, growing acceptance of CBD, key manufacturers, and supportive laws like the U.S. Farm Bill contribute to this trend. The region is a hub for cannabis innovation, with numerous CBD companies and favorable regulations boosting market expansion.
Market Competitive Landscape:
The global Cannabidiol Market is highly consolidated. Some of the market key players are ENDOCA, NuLeaf Naturals, LLC, Isodiol International, Inc., PharmaHemp, The Cronos Group, Cannoid, LLC, Medical Marijuana, Inc., Folium Europe B.V., Canopy Growth Corporation, Elixinol.
Recent Developments:
In June 2024, Rodedawg International Industries, Inc., a cannabis manufacturer and distributor, launched Nutrient CBD, a new product line featuring five innovative SKUs. The lineup includes two CBD oil tinctures, two CBD creams, and one CBD roll-on, designed to cater to the diverse needs of consumers looking for natural and effective wellness solutions.
In January 2023, Medical Marijuana, Inc. announced that its subsidiary, HempMeds Brasil, introduced two new full-spectrum products in Brazil. These products come in concentrations ranging from 3,000 to 6,000 mg and are offered in 30 mL and 60 mL jars.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Source Type, By Sales Type, By End Use |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | ENDOCA, NuLeaf Naturals, LLC, Isodiol International, Inc., PharmaHemp, The Cronos Group, Cannoid, LLC, Medical Marijuana, Inc., Folium Europe B.V., Canopy Growth Corporation, Elixinol. |
- Global Cannabidiol Market Size (FY 2021-FY 2034)
- Overview of Global Cannabidiol Market
- Segmentation of Global Cannabidiol Market By Source Type (Hemp, Marijuana)
- Segmentation of Global Cannabidiol Market By Sales Type (B2B, B2C, By Sales Channel, Hospital Pharmacies, Online, Retail Stores)
- Segmentation of Global Cannabidiol Market By End Use (Medical, Personal Use, Pharmaceuticals, Wellness, Food & Beverages, Personal Care & Cosmetics, Nutraceuticals, Others)
- Statistical Snap of Global Cannabidiol Market
- Expansion Analysis of Global Cannabidiol Market
- Problems and Obstacles in Global Cannabidiol Market
- Competitive Landscape in the Global Cannabidiol Market
- Details on Current Investment in Global Cannabidiol Market
- Competitive Analysis of Global Cannabidiol Market
- Prominent Players in the Global Cannabidiol Market
- SWOT Analysis of Global Cannabidiol Market
- Global Cannabidiol Market Future Outlook and Projections (FY 2025-FY 2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Cannabidiol Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cannabidiol Market
7. Global Cannabidiol Market, By Source Type, (USD Million) 2021-2034
- 7.1. Hemp
- 7.2. Marijuana
8. Global Cannabidiol Market, By Sales Type, (USD Million) 2021-2034
- 8.1. B2B
- 8.2. B2C
- 8.3. By Sales Channel
- 8.4. Hospital Pharmacies
- 8.5. Online
- 8.6. Retail Stores
9. Global Cannabidiol Market, By End Use, (USD Million) 2021-2034
- 9.1. Medical
- 9.1.1. Chronic Pain
- 9.1.2. Mental Disorders
- 9.1.3. Cancer
- 9.1.4. Others
- 9.2. Personal Use
- 9.3. Pharmaceuticals
- 9.4. Wellness
- 9.5. Food & Beverages
- 9.6. Personal Care & Cosmetics
- 9.7. Nutraceuticals
- 9.8. Others
10. Global Cannabidiol Market, (USD Million) 2021-2034
- 10.1. Global Cannabidiol Market Size and Market Share
11. Global Cannabidiol Market, By Region, 2021-2034 (USD Million)
- 11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
- 11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
- 11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
- 11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
- 11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America
12. Company Profile
- 12.1. ENDOCA
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
- 12.2. Cannoid, LLC
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
- 12.3. Medical Marijuana, Inc.
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
- 12.4. Folium Europe B.V.
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
- 12.5. Canopy Growth Corporation
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
- 12.6. Elixinol
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
- 12.7. NuLeaf Naturals, LLC
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
- 12.8. Isodiol International, Inc
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
- 12.9. PharmaHemp
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
- 12.10. The Cronos Group
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
- 12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Cannabidiol Market is projected to reach USD 40.01 billion by 2034, growing at a CAGR of of 16.06% during the forecast period.
Cannabidiol Market grew in Market size from 2025. The Market is expected to reach USD 40.01 billion by 2034, at a CAGR of 16.06% during the forecast period.
Cannabidiol Market CAGR of 16.06% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Cannabidiol Market size is USD 40.01 billion from 2025 to 2034.
Cannabidiol Market is covered By Source Type, By Sales Type, By End Use
The North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa is the highest Market share in the Cannabidiol Market .
ENDOCA, NuLeaf Naturals, LLC, Isodiol International, Inc., PharmaHemp, The Cronos Group, Cannoid, LLC, Medical Marijuana, Inc., Folium Europe B.V., Canopy Growth Corporation, Elixinol.
The report includes an in-depth analysis of the Global Cannabidiol Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
